Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    NAA15
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
Conditions: Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: irinotecan hydrochloride;   Biological: bevacizumab;   Drug: temozolomide
2 Unknown  The Natural History of Traumatic Spinal Cord Injury Using fMRI, MRS and DTI
Condition: Central Cord Syndrome
Intervention:
3 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate
4 Completed SB-773812 Administered In Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SB-773812;   Drug: Olanzapine
5 Active, not recruiting MRI and PET Scan Using 18F-Fluoromisonidazole In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Drug: 18F-Fluoromisonidazole;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging

Indicates status has not been verified in more than two years